Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction

Authors

  • Inara Khayretdinova

  • Zarifjon Ashurov

  • Nargiza Yadgarova

Keywords:

screening, MOSA test, cognitive dysfunction, poly addiction, combined addiction, hashish, tramadol

Abstract

Abstract not found

How to Cite

Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction. (2020). Global Journal of Medical Research, 20(A3), 1-7. https://medicalresearchjournal.org/index.php/GJMR/article/view/2265

References

(2020) UNODC/WHO International Standards for the Treatment of Drug Use Disorders.

H Curran, Tom Freeman, Claire Mokrysz, David Lewis, Celia Morgan, Loren Parsons (2016) Keep off the grass? Cannabis, cognition and addiction. 17(5), 293-306.

M Field, W Cox (2008) Attentional bias in addictive behaviors: A review of its development, causes, and consequences. 97(1-2), 1-20.

C Perry, A Lawrence (2017) Addiction, cognitive decline and therapy: seeking ways to escape a vicious cycle. 16(1), 205-218.

Nora Volkow, James Swanson, A Evins, Lynn Delisi, Madeline Meier, Raul Gonzalez, Michael Bloomfield, H Curran, Ruben Baler (2016) Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. 73(3), 292.

Egon Hagen, Aleksander Erga, Katrin Hagen, Sverre Nesvåg, James Mckay, Astri Lundervold, Espen Walderhaug (2016) Assessment of Executive Function in Patients With Substance Use Disorder: A Comparison of Inventory- and Performance-Based Assessment. 66, 1-8.

T Gould (2010) Addiction and cognition. 5(2), 4-14.

Claudia Juárez, Tania Molina-Jiménez, Jean-Pascal & Morin, Roldán-Roldán, & Gabriel, Rossana Zepeda (2018) Influence of Drugs on Cognitive Functions.

T Agibalova, K Poplevchenkov (2012) Clinical symptoms and personality traits in patients using psychostimulant drugs and other psychoactive substances. 118(1), 10.

Marc Copersino (2017) Cognitive mechanisms and therapeutic targets of addiction. 13, 91-98.

R Wiers, A Stacy (2006) Implicit Cognition and Addiction. 15(6), 292-296.

V Yaltonsky, N Sirota, A Yaltonskaya (2017) The combined use of drugs and other psychoactive substances by adolescents as an urgent problem of narcology. // Issues of narcology. 83, 88.

Medhat Bassiony, Usama Youssef, Mervat Hassan, Ghada Salah El-Deen, Hayam El-Gohari, Mohamed Abdelghani, Ahmed Abdalla, Dalia Ibrahim (2017) Cognitive Impairment and Tramadol Dependence. 37(1), 61-66.

Y Miao, J Tian, J Shi, M Mao (2012) Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: A randomized, double-blind and parallel-controlled trial. 10(4), 390-397.

Amir Levine, Kelly Clemenza, Moira Rynn, Jeffrey Lieberman (2017) Evidence for the Risks and Consequences of Adolescent Cannabis Exposure. 56(3), 214-225.

Dan Lubman, Ali Cheetham, Murat Yücel (2015) Cannabis and adolescent brain development. 148, 1-16.

A Shrivastava, M Johnston, M Tsuang (2011) Cannabis use and cognitive dysfunction. 53(3), 187-191.

L Tursunkhojaeva, T Rustamova Zh (2007) Comparative assessment of memory functions in patients with opium-hashish poly drug addiction and opium mono-drug addiction // Neurology. 334.

Marc Copersino, David Schretlen, Garrett Fitzmaurice, Scott Lukas, Judith Faberman, Jody Sokoloff, Roger Weiss (2012) Effects of Cognitive Impairment on Substance Abuse Treatment Attendance: Predictive Validation of a Brief Cognitive Screening Measure. 38(3), 246-250.

Mehmet Sofuoglu (2010) Cognitive enhancement as a pharmacotherapy target for stimulant addiction. 105(1), 38-48.

Marc Copersino, William Fals-Stewart, Garrett Fitzmaurice, David Schretlen, Jody Sokoloff, Roger Weiss (2009) Rapid cognitive screening of patients with substance use disorders.. 17(5), 337-344.

Linwei Wang, Jeong Min, Emanuel Krebs, Elizabeth Evans, David Huang, Lei Liu, Yih-Ing Hser, Bohdan Nosyk (2017) Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. 49, 32-40.

A Polunina, D Davydov, E Brun (2004) Neuropsychological studies of cognitive impairments in alcoholism and drug addiction // Psychological journal. 25, 70-76.

Sultanov Sh, Kh, N Khodzhaeva, A Kharyakova (2019) Correction of cognitive impairments in heroin addiction with the nootropic drug alcheba (memantine) // Anthology of Russian psychotherapy and psychology. 168.

J Allan, S Collings, A Munro (2019) The process of change for people with cognitive impairment in a residential rehabilitation program for substance problems: a phenomenographical analysis. 14(1), 13.

K Carroll, B Kiluk, C Nich, T Babuscio, J Brewer, M Potenza, S Ball, S Martino, B Rounsaville, C Lejuez (2011) Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitivebehavioral therapy. 46(1), 23-34.

Sara Domínguez-Salas, Carmen Díaz-Batanero, Oscar Lozano-Rojas, Antonio Verdejo-García (2016) Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways. 71, 772-801.

Antonio Yam, Trevor Chong, Julie Stout, Yucel, Edythe Murat & London (2017) Stages of dysfunctional decision-making in addiction. 164.

K Willock, Н Сапронов (2010) Screening Drug and Alcohol participants for mild cognitive impairment: why, how and does it matter? 30. 10, 229.

Ziad Nasreddine, Natalie Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey Cummings, Howard Chertkow (2005) The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. 53(4), 695-699.

Parunyou Julayanont, Natalie Phillips, Howard Chertkow, Ziad Nasreddine (2013) Montreal Cognitive Assessment (MoCA): Concept and Clinical Review. 111-151.

А Ivkin, E Grigoriev, D Shukevich (2018) DIAGNOSTICS OF COGNITIVE DYSFUNCTION IN PATIENTS IN THE INTENSIVE CARE WARDS. 15(3), 47-55.

John Hobson (2015) The Montreal Cognitive Assessment (MoCA). 65(9), 764-765.

Alessandra Thomann, Nicolai Goettel, Raphael Monsch, Manfred Berres, Thomas Jahn, Luzius Steiner, Andreas Monsch (2018) The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples. 64(2), 643-655.

Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction

Published

2020-10-24

How to Cite

Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction. (2020). Global Journal of Medical Research, 20(A3), 1-7. https://medicalresearchjournal.org/index.php/GJMR/article/view/2265